Opinion|Podcasts|February 5, 2025

Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBC

Author(s)Max Kates, MD, Neal Shore, MD, FACS, Tom Jayram, MD

Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.

Episodes in this series

EP. 1 Episode 1: Advancing Patient Care in Non–Muscle-Invasive Bladder Cancer

EP. 1 Episode 1: Advancing Patient Care in Non–Muscle-Invasive Bladder Cancer

EP. 2 Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC

EP. 2 Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC

EP. 3 Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBC

EP. 3 Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBC

EP. 4 Episode 3 Podcast: Treatment Strategies to Tackle NMIBC Heterogeneity

EP. 4 Episode 3 Podcast: Treatment Strategies to Tackle NMIBC Heterogeneity

EP. 5 Episode 3 Video: Treatment Strategies to Tackle NMIBC Heterogeneity

EP. 5 Episode 3 Video: Treatment Strategies to Tackle NMIBC Heterogeneity

EP. 6 Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

EP. 6 Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

EP. 7 Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

EP. 7 Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

The UroOnc Minute: Perioperative Intravesical Chemotherapy at Nephroureterectomy, With Surena F. Matin, MD, FACS

ByAdam B. Weiner, MD,Surena F. Matin, MD, FACS

September 4th 2026

Pearls & Perspectives: Sexual Wellness and Premature Ejaculation, With Chris Harris, MBA

ByAmy M. Pearlman, MD,Chris Harris, MBA

September 3rd 2026

Pearls & Perspectives: From Emergency Medicine to Sexual Medicine, With Jeff Myers, DO

ByAmy M. Pearlman, MD,Jeff Myers, DO

August 26th 2026

The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD

ByAdam B. Weiner, MD,Tyler Seibert, MD, PhD

August 21st 2026

The Expert APProach: Advancing APP Leadership and Expertise in Urology, With Susanne Quallich, PhD, ANP-BC, NP-C

ByJoy Maulik, CRNP,Susanne A. Quallich, PhD, ANP-BC, NP-C, CUNP, CMHE, FAUNA, FAANP

August 20th 2026

Latest CME

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

What the Efficacy Data from KEYNOTE-B15/EV-304 Revealed

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

Higher saturated fat intake associated with increased mortality in nonmetastatic prostate cancer

FDA reports increased demand, supply efforts for estradiol transdermal patches

NeoBLAST trial tests active surveillance after complete response in MIBC